NCT06048185View on ClinicalTrials.gov

Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study

Active, not recruitingOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

October 19, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

July 31, 2027

Conditions
Stargardt Disease
Interventions
BIOLOGICAL

Gene Therapy Product-MCO-010

The MCO-010 is an adeno-associated virus serotype 2-based vector carried multi-characteristic opsin (MCO) gene expression cassette

Trial Locations (2)

33136

Nanocope Clnical Site, Miami

78503

Nanoscope Clinical Site, McAllen

Sponsors
All Listed Sponsors
lead

Nanoscope Therapeutics Inc.

INDUSTRY